Clinical-Pathological Study on Incidental Prostate Cancer in Patients Operated Under the Assumed Diagnosis of Symptomatic BPH

This retrospective study analyzed 1,593 patients who underwent prostate surgery for symptomatic benign prostatic hyperplasia (BPH) and found incidental prostate cancer (CPI) in 78 cases, with a prevalence of 4.89% and an incidence of 13 cases per year. The study spanned 6 years and included two surgical methods: suprapubic prostatectomy (APS) and transurethral resection of the prostate (RTU-P). The average age was 73.6 years, and the average PSA level was 6 ng/ml. Most tumors were well-differentiated and in stage pT1a. A watchful waiting approach was chosen for 57% of patients, with a 13.3% tumor progression rate and a 2.6% CPI-specific mortality over an average follow-up of 47.19 months. No significant differences in CPI prevalence were observed between the APS and RTU-P groups.